Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early <i>ERBB2</i>-Positive Breast Cancer

Authors

Institutions

Publication Details

Journal
JAMA Oncology
Published
2025-02-13
DOI
https://doi.org/10.1001/jamaoncol.2024.6872
Citations
13
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
11.23

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer

Alessio Schirone, Davide Massa, Katia Cagossi, Ornella Garrone et al.
13 citations
JAMA Oncology
Breast Cancer Treatment Studies
11.23
article

Tumor-Infiltrating Lymphocytes and Survival Outcomes in Early ERBB2-Positive Breast Cancer

Alessio Schirone, Davide Massa, Katia Cagossi, Ornella Garrone, Anita Rimanti, Federica Miglietta, Roberto D’Amico, Melinda E. Sanders, Samanta Sarti, Stefania Bartolini, Valentina Guarneri, Pierfranco Conté, Sara Balduzzi, Giancarlo Bisagni, Antonino Musolino, Enrico Orvieto, Luigi Cavanna, Federico Piacentini, Antonella Ferro, Elena Bertone, Maria Vittoria Dieci, Francesco Giotta
article en
13 citations

Abstract

No abstract available for this paper.
JAMA OncologyVol. 11(4)
University of Modena and Reggio Emilia (IT), University of Padua (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Ospedale Santa Chiara (IT), Istituto Ramazzini (IT), AULSS 2 Marca Trevigiana (IT), Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IT), Ospedale Sant'Anna (IT), Azienda Ospedaliero-Universitaria di Modena (IT), Istituto Oncologico Veneto (IT), Istituto delle Scienze Neurologiche di Bologna (IT), Istituto Tumori Bari (IT), Ospedaliera di Piacenza (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), Azienda Ospedaliera Carlo Poma (IT), Vanderbilt University Medical Center (US), University of Bologna (IT)
Eli Lilly and Company, AstraZeneca, Gilead Sciences, Università degli Studi di Padova, Istituto Oncologico Veneto
Good health and well-being
Openalex Percentile: Top 1%
Breast Cancer Treatment Studies
11.23
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.